Atlas Trials

Acute Intermittent Porphyria

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Intermittent Porphyria

RecordFirmDate
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) (NCT03338816)Alnylam Pharmaceuticals2017-11-16
Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride (NCT02943213)Cycle Pharmaceuticals Ltd.2016-11-01
A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP) (NCT02949830)Alnylam Pharmaceuticals2016-10-01
Panhematin for Prevention of Acute Attacks of Porphyria (NCT02922413)The University of Texas Medical Branch, Galveston2015-10-30
A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP) (NCT02452372)Alnylam Pharmaceuticals2015-05-06
Acute Porphyria Biomarkers for Disease Activity (NCT02935400)The University of Texas Medical Branch, Galveston2014-04-28
Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria (NCT02082860)Digna Biotech S.L.2012-11-01
Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP) (NCT01617642)Nordlandssykehuset HF2012-07-01
Observational Study of Acute Intermittent Porphyria Patients (NCT02076763)Digna Biotech S.L.2011-08-01
Porphozym in the Treatment of Acute Attacks in AIP (NCT00418795)Zymenex A/S2003-06-11

Track Acute Intermittent Porphyria automatically

Every clearance here is in the API, with alerts when new ones post.